Find and Pitch Jounalists, Get Your Story Covered

Tags: smart home wi-fi shopping buying guides routers

	Profile	Recent Articles on Subject
1	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Immunotherapy and Chemotherapy Combinations Show Promise for High-Risk HR+/HER2– Breast Cancer - about 1 month ago Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Is New Standard of Care for High-Risk Early-Stage TNBC - 2 months ago Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 2 months ago Advancements in HER2+ Breast Cancer Treatment: Insights From the HER2CLIMB-02 Trial - 9 months ago
2	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Expert Discusses Immunotherapy, Antibody Drug Conjugates for Lung Cancer - 2 months ago FDA Grants Fast Track Designation to Potential Treatment for Clear Cell Renal Cell Carcinoma - 5 months ago Neoadjuvant Chemotherapy Could Help Patients With Breast Cancer Skip Regional Nodal Irradiation - 10 months ago
3	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GSK5764227 Receives Breakthrough Therapy Designation to Treat Extensive-Stage Small–Cell Lung Cancer - 3 months ago FDA Grants Breakthrough Therapy Designation to DS-8201a and T-DXd to Treat Metastatic Breast Cancer - 3 months ago Researchers Highlight Need for Additional Research in Advanced Non–Small Cell Lung Cancer - 10 months ago
4	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: FDA approves innovative T cell immunotherapy for rare soft-tissue cancer - 4 months ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Positive Data in Pancreatic Cancer Pave Way for Pivotal Test of Revolution Medicines Drug - 4 months ago
6	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 4 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 8 months ago ASTRO Updates Guidelines on Partial Breast Irradiation for Early Invasive Cancer - about 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago
7	Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. HealthcareEditing	The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - 5 months ago
8	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Novel TKI Promising in Early Study of HER2-Mutant NSCLC - 5 months ago KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - 12 months ago The Treatment Landscape for Cervical Cancer Has Changed - 12 months ago The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer - about 1 year ago What's New in Targeted Lung Cancer Treatment? - about 1 year ago
9	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective - 5 months ago Alternative Treatments for eBC and mBC - 6 months ago Balancing Clinical and Economic Factors in Early Breast Cancer Treatment - 6 months ago Key Points of Emphasis Surrounding CDK4/6 Inhibitor in mBC Treatment - about 1 year ago Navigating Medication Therapy Management in mBC Treatment - about 1 year ago NCCN Guidelines on CDK4/6 Inhibitor Treatment Regimens - about 1 year ago Differentiating Between Adverse Event Profiles of Various CDK4/6 Inhibitors - about 1 year ago Progression-Free Survival and Overall Survival Associated With CDK4/6 Inhibitor Therapy - about 1 year ago
10	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Translating ctDNA Detection into Breast Cancer Research Breakthroughs - 7 months ago

Journalists covering breast cancer,early breast cancer,breast cancer treatment,early breast cancer treatment,CDK4/6 inhibitors,chemotherapy,patient selection,best candidates,treatments,therapies